Form D · Biotechnology

LIVING CELL TECHNOLOGIES LTD

Auckland, Q2 · CIK 0001399927

Offering snapshot reported Jan 18, 2011 · SEC filing

Reported sold
$5.64M
Offering amount: $5.64M
Investors reported
1
Form D · investor count
Minimum accepted
$5.64M
Reported outside-investor minimum
First sale
Jan 4, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.82M$5.64MJan 13, 2011: $637,630.00Jan 13, 2011Jan 18, 2011: $5,640,573.00Jan 18, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$637,630 → $5,640,573
  • Minimum accepted$1,000 → $5,640,573

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 18, 2011Amendment$5,640,573$5,002,943vs Jan 13, 20111SEC filing
Jan 13, 2011Initial$637,630No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-153601

Source: Form D, filed Jan 18, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Susanne Christine Clay Executive
John Alfred Cowan Executive
Robert Bartlett Elliott Director
Robert Andrew Finder Director
John Laurie Hunter Director
Ross Alexander Macdonald Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
19 Laureston Avenue Papatoetoe
Auckland, Q2, 2155